Trisodium citrate versus heparin for locking tunnelled haemodialysis catheters: a randomised controlled trial

ISRCTN ISRCTN27307877
DOI https://doi.org/10.1186/ISRCTN27307877
Secondary identifying numbers N0158153706
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
08/09/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr M Abdalla
Scientific

Nephrology Department
North Staffordshire Royal Infirmary
Princes Road
Hartshill
Stoke-on-Trent
ST4 7LN
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typePrevention
Scientific title
Study objectivesTo compare the effectiveness of 46.7% trisodium citrate versus unfractionated heparin (5000 IU/ml) in preventing clotting of tunnelled haemodialysis catheters.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedRenal failure
InterventionTrisodium citrate versus heparin for locking tunnelled haemodialysis catheters.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Trisodium citrate, unfractionated heparin
Primary outcome measureCatheter blood flow of less than 250 ml/minute and/or venous pressure of more than 260 mmHg, persisting for one hour/session, in two consecutive sessions.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/02/2005
Completion date01/08/2006

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participantsNot provided at time of registration
Key inclusion criteriaAny patient who require a new tunnelled catheter for haemodialysis. Patients fall into three groups:
1. Patients who present to the kidney unit of the UHNS with kidney failure needing maintenance haemodialysis
2. Patients who have to switch from peritoneal to haemodialysis because of problems with their peritoneal dialysis
3. Existing haemodialysis patients who need tunnelled catheters because their arterivenous fistulas or tunnelled catheters have failed
The decision to place a tunnelled dialysis catheter is made by one of the renal consultants entirely on the basis of clinical need. Patients will be invited to take part prior to insertion of the tunnelled dialysis catheter. Randomisation will be by sealed envelopes. The only differences in dialysis care that patients will have is the locking agent, otherwise patients will have the same treatment whether they are dialysing in our main renal unit in Stoke or our two satellite units at Stafford and Leighton. They will be followed up and all dialysis-related issues will be documented as per current practice.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/02/2005
Date of final enrolment01/08/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Nephrology Department
Stoke-on-Trent
ST4 7LN
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

North Staffordshire Research and Development Consortium (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan